Quanterix Investor Relations Material
Latest events
Investor Update
Quanterix
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Quanterix Corporation
Access all reports
Segment Data
Access more data
Revenue by
Source
Product revenue
Service and other revenue
Collaboration revenue
Grant revenue
Expenses by
Financials
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's proprietary platform offers high sensitivity to detect various proteins at concentrations as low as one part per trillion. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Key slides for Quanterix Corporation
Q4 2023
Quanterix Corporation
Q4 2023
Quanterix Corporation
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States